This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked IL10RA Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-IL10RA WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~63 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Phosphorylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A03597 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Target-positive lysate and matched negative control (standard starting point) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A03597; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
IL10RA has a predicted 63 kDa precursor; glycosylation and signal-peptide cleavage may affect migration, but no empirical band size is available.
| Band near 63 kDa | Consistent with the predicted precursor mass; identity requires controls |
| Band above 63 kDa | N-linked glycans could increase apparent mass |
| Band slightly below 63 kDa | Signal-peptide cleavage could reduce mass |
| Broad smear | Variable N-linked glycosylation is possible |
| Multiple nearby bands | Different glycosylation states are possible; identity requires controls |
| Predicted precursor mass | Provides a 63 kDa sequence-based reference |
| N-linked glycosylation at Asn50, Asn74 and Asn110 | May increase apparent mass if these sites carry glycans |
| N-linked glycosylation at Asn154, Asn177 and Asn189 | May increase apparent mass if these sites carry glycans |
| Signal peptide at residues 1–21 | Cleavage makes the mature protein smaller than the precursor |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | N-linked glycosylation may alter migration | Compare untreated and deglycosylated samples with an identity control |
| Band lower than expected | Signal-peptide cleavage may lower mass | Check whether the antibody recognizes the mature receptor and confirm identity |
| Broad smear instead of sharp band | Variable glycosylation at the six N-linked sites is possible | Compare with a deglycosylated aliquot |
| Multiple bands | Different glycosylation states or unrelated antibody binding are possible | Compare deglycosylated samples and verify bands with a second antibody |
| Weak or no signal | The membrane receptor may be poorly recovered in the lysate | Check membrane extraction and include a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for IL10RA, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A03597 is a polyclonal anti-IL10RA antibody listed as reactive with Human and Mouse samples. The supplied record includes a WB image and a caption describing SDS-PAGE analysis of cells. No publication evidence is supplied.
Which to pick: A03597 is the only listed antibody. It has a WB image and reports Human and Mouse reactivity; check the full validation details for a sample and conditions relevant to your experiment.